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oligodendroglioma and the rest had GBM. There was a clear 
inverse correlation between Ki-67 percentage staining and 
overall survival. In patients with Ki-67 ≤ 30% (n=18), 5 year 
survival was approximately 50% compared to those with Ki-67 
>30% (n=60) with survival of 10% (logrank P-value 0.02, HR 
0.39, 95% CI 0.17 – 0.88). 
 
Conclusion: There appears to be a correlation between 
percentage staining of Ki-67 and overall survival in patients 
with HGG. Percentage staining of Ki-67 > 30% appears to 
predict for poorer survival in HGG. 
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Purpose or Objective:Background and purpose:In this 
retrospective evaluation, we correlated radiation dose 
parameters with occurrence of optical radiation-induced 
toxicities. 
 
Material and Methods: Patients and methods:213 
meningiomapatientsreceived radiation between 2000 and 
2013. Radiation dose and clinical datawere extracted from 
planning systems and patients’ files. The range of follow-up 
period was 2-159 months (median:75 months). 
 
Results: Results:Median age of patients was 60 years (range: 
23-86). There were163 female and 50 male patients. In 140 
cases, at least one of the neuro-optic structures (optic nerves 
and chiasm) was inside the irradiatedtarget volumes. We 
found 15 dry eye (7%) and 24 cataract (11.2%) cases. Median 
dose to affected lachrymal glands was 1.47Gy and median 
dose to affected lenses was1.05Gy. Age and blood cholesterol 
level in patients with cataract were significantly higher. 
Patients with dry eye were significantly older. Only 2 patients 
with visual problems attributable to radiation treatment 
(RION) were seen. They did not have any risk factors. 
Maximum and median delivered doses to neuro-optic 
structures were not higher than 57.30Gy and 54.60Gy 
respectively. 
 
Conclusion: Conclusion:Low percentages of cases with 
radiation induced high grade optic toxicities show that 
modern treatment techniques and doses are safe. In very few 
patients with optic side effects, doses to organs at risk were 
higher than the defined constraint doses. This observation 
leads to the problem of additional risk factors coming into 
play. The role of risk factors and safety of higher radiation 
doses in high grade meningiomas should be investigated in 
more comprehensive studies. 
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Purpose or Objective: Evaluating the radiation doses 
delivered to different parts of the visual pathway for better 
understanding of light vision in radiotherapy patients. 
 
Material and Methods: 20 patients with brain tumors and 
head and neck malignancies who received radiotherapy and 
experienced any kind of light or color vision during radiation 
treatment. All the components of visual pathway including 
lenses, eyeballs, retinas, optic nerves, chiasm, optic tracts, 
optic radiations and visual occipital cortexes were contoured. 
 
Results: 11 patients were male (55%) and 9 were female 
(45%). Age median was 56 years. The range of dose/fraction 
and total prescribed dose were 1.8-3 Gy and 36-70.4 Gy 
respectively. Twelve patients reported white, 11, blue, 2, 
yellow and 2, gray color visions. Seven patients experienced 
more than one color, while 2 patients did not attribute any 
special color to their light seeing experiences. Four patients 
had a kind of smell experience and 1 patient had a taste 
experience. 
 
Conclusion: Cherenkov radiation in eye ballsmay be the 
origin of light seeing experiences in patients receiving 
radiation treatment for head and neck malignancies, since 
treatmentsareperformed with ionizing radiations with 
energycapable to produce this effect. Also this effectmay be 
due to phosphenes produced by radiation treatment in 
different parts of the visual pathway (from retina to visual 
cortex). In order to investigate the mechanism of this 
phenomenon in patients and to define a radiation dose 
threshold – if the origin of this phenomenon is phosphenes 
produced in visual pathway – larger studies are needed. 
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Purpose or Objective: Ependymomas are central nervous 
system (CNS) tumors that due to their rare prevalence have 
considerable controversy regarding their prognostic factors 
and clinical management. As such, many of the reported 
series involve accumulation of patient data that spans many 
decades, making current management decisions difficult. In 
this study, we report the outcomes and possible prognostic 
factors of patients with histologically confirmed 
infratentorial ependymomas treated in the modern era. 
 
Material and Methods: A retrospective chart review of our 
patient registry was conducted to identify 15 patients 
diagnosed with infratentorial ependymoma between 2007—
2013. Mean age at diagnosis was 29 years (range 1.0—79.0 
years). There were 8 males and 7 females, with headache 
being the most common presenting symptom among the 
entire cohort. Eleven were newly diagnosed with 
ependymoma and the remaining 4 were recurrent patients 
who had failed primary therapy. Of the newly diagnosed 
patients, all received surgery and post-operative radiation 
therapy (RT) with a mean dose of 54.3 Gy (range 45.0—59.4 
Gy). Two also received chemotherapy. Patients in the 
recurrent group experienced only local recurrences after 
initial treatment and underwent salvage RT with a mean dose 
of 45.6 Gy (range 15.0—59.4 Gy). 
 
Results: With a mean follow-up time of 15 months (range 
1.4—61.7 months) for the cohort, a significant difference in 
overall survival (OS) was found between primary and 
recurrent patients (p=0.0082). Overall, 9 patients (60%) had 
no acute complications with the remainder Grade I or II 
following initial treatment. All were free of late 
complications throughout follow-up. Moreover, there were no 
statistically significant differences in OS or local control 
when tumor size or RT dose were analyzed.  
 
Conclusion: Our findings indicate that recurrence is a 
prognostic factor for decreased OS in patients with 
infratentorial ependymomas. Involved field radiation therapy 
following surgical resection of these tumors offers high local 
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control rates and may ultimately improve OS. The 
combination of surgery followed by RT appears to be the 
current standard of care.  
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Purpose or Objective: To elucidate the radiobiological 
effects of stereotactic radiosurgery (SRS) on brain metastases 
using autopsy cases. 
 
Material and Methods: From 1995 to 2013, 9 brain specimens 
from 3 patients were available. They underwent autopsy 
after SRS in our hospital. These specimens were all brain 
metastases. The timing of autopsy was from 7 days to 20 
months (median 10 months) after SRS. The 9 tumors received 
a margin dose of 16–20 Gy (median 20 Gy) at the 40–75% 
isodose line (median 40%), with a maximal dose of 16–50 Gy 
(median 45 Gy). Histopathological investigations were 
performed. The specimens were fixed in 20% neutral buffered 
formaldehyde and embedded in paraffin. Hematoxylin-eosin, 
Azan-Mallory, and Bodian stains were used. 
Immunohistochemical reactions included glial fibrillary acidic 
protein, alpha-smooth muscle actin, CD34, and CD68 
antigens. Ki67 and p53 reactions were also used. 
 
Results: The first case was a 59-year-old man diagnosed with 
2 brain metastases from renal cell carcinoma. Both lesions 
were irradiated with SRS. He received SRS 4 times after the 
first SRS. At 1 week after the last SRS, he died from 
carcinomatous lymphangiosis. The second case was a 63-year-
old man diagnosed with 2 brain metastases from lung cancer. 
Both lesions were irradiated with SRS plus whole brain 
radiotherapy (WBRT). Seven months later, he died from 
carcinomatous peritonitis. The third case was a 35-year-old 
woman diagnosed with 2 brain metastases from breast 
cancer. Both lesions were irradiated with WBRT plus SRS. 
When one of the lesions enlarged 1 year later, repeated SRS 
was performed. At 7 months after reirradiation, she died 
from carcinomatous lymphangiosis. In the first case, necrosis 
and viable tumor cells were observed mainly in the center of 
the lesion at 1 week after SRS, while apoptosis and fibrosis 
were observed in a small part of the lesion. Glial cells and 
neutrophilic leukocytes had accumulated around the lesion. 
In the lesions at 2 months after SRS, tumor cells and fibrosis 
were not observed; only macrophages and glial cells were 
observed in the SRS irradiated field. In the second case, 
fibrosis was observed at the periphery of the center necrotic 
region at 7 months after SRS. In the third case, almost all 
parts of the lesions were replaced with fibrosis at 19 months 
after SRS, while small foci of viable tumor cells, a large 
number of glial cells, and macrophages were observed around 
the fibrotic area. 
 
Conclusion: In the tumors, apoptosis was only observed at 1 
week after SRS. The time of fibrosis initiation varied in each 
case. Around the tumors, neutrophilic leukocytes and glial 
cells accumulated within 1 week after SRS. Macrophages 
accumulated at least 2 months after SRS. Stromal changes 
remained for a considerable period of time. It was 
remarkable that fibrosis occurred very soon after SRS, and 
other observations were generally compatible with previous 
reports. 
 
EP-1116  
Staged radiosurgery for petroclival meningiomas: 
preliminary results 
V. Pinzi
1IRCCS Istituto C. Besta, Neurosurgery Radiotherapy Unit, 
Milan, Italy 
1, M. Marchetti1, I. Milanesi1, E. De Martin2, L. 
Fariselli1 
2IRCCS Istituto C. Besta, Health Department-, Milan, Italy 
 
Purpose or Objective: The goal of surgical treatment of 
meningiomas is the total resection of the tumour. The 
complete removal of petroclival meningiomas can be difficult 
because of their proximity to cranial nerves. Stereotactic 
radiosurgery (SRS) is a well established treatment for many 
patients with intracranial meningiomas, either in the 
exclusive or adjuvant setting. However, SRS of large 
meningiomas might be associated with significant morbidity. 
Under these circumstances s-SRS has the potential to deliver 
sharply focused high doses per fraction without increasing the 
risk of toxicity.The aim of this study is to prospectively 
evaluate the feasibility of s-SRS for petroclival meningiomas, 
including large volume lesions. 
 
Material and Methods: Between September 2011 and 
October 2013 at our Institute, s-SRS using the CyberKnife was 
prospectively performed on 30 patients (24 women and 6 
men, men, mean age 57 years) with petroclival meningiomas. 
Patients with atypical or malignant meningiomas and those 
who had received prior radiotherapy were excluded. The 
average tumor volume was 11,86 cm3 (range 2,2–126,3 cm3); 
the average tumor prescription dose was 24,4 Gy, the number 
of fraction was 4 or 5. 
 
Results: After a median follow-up of 30 months (range 13-36 
months ) the overall tumour control rate was 100% (25 
patients with stable disease, 3 patients with partial response 
and 2 patients with complete response). Tumor control rates 
at 2 and 3 years was 100%. Among 28 patients who were 
symptomatic before staged radiosurgery, neurological follow-
up showed an improvement in 43%, stable clinical course in 
43% and a persistent deterioration of clinical symptoms in 
14% of the patients. A transient neurological deterioration 
was observed in 11% of patients within the first year after 
treatment. 
 
Conclusion: Our findings show that s-SRS using the 
CyberKnife is a safe and effective option in the treatment of 
large-volume petroclival meningiomas. A good tumour control 
and a low morbidity rate was achieved in our series, either as 
a primary or adjuvant approach. Long-term follow-up is 
warranted to confirm these results. 
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Purpose or Objective: Frameless radiosurgery (SRS) plays an 
important role in the management of acoustic neuromas. This 
retrospective study aims to evaluate tumor control using this 
technique.  
 
Material and Methods: Thirty four patients with unilateral 
acoustic neuromas (vestibular schwannomas) who underwent 
linear accelerator-based frameless SRS at low dose (12 Gy) to 
the tumor from July 2008 to February 2015 were evaluated. 
Twenty-one patients were male and 13 patients were female. 
The median age was 62 years (range 23-84) with a median 
follow-up period of 12.4 months (range 1-60). Treatment 
volume was 0.1 to 3.8 cm3 (median 0.93 cm3 ). 
 
Results: Preliminary results from follow-up magnetic 
resonance imaging (MRI) showed: the tumor of 15 patients 
decreased in diameter, no changes was found in 14 and the 
tumor increased slightly in only one patient. All patients are 
alive, except for 1p who died from intercurrent disease 2 
years after radiosurgery. Among 23p with acufeno, full 
improvement was demonstrated in four. There were no 
reported complications related to treatment.  
